Translate this page into:
Metastatic squamous cell carcinoma complicating a chronic leprosy ulcer: Highlighting the need for long-term surveillance of ‘cured’ leprosy patients
Corresponding author: Dr. Vishal Gupta, Department of Dermatology and Venereology, All India Institute of Medical Sciences, New Delhi, India. doctor.vishalgupta@gmail.com
-
Received: ,
Accepted: ,
How to cite this article: Anand GRP, Pragya P, Dixit S, Damle N, Gaurav V, Bakhshi S, et al. Metastatic squamous cell carcinoma complicating a chronic leprosy ulcer: Highlighting the need for long-term surveillance of ‘cured’ leprosy patients. Indian J Dermatol Venereol Leprol. doi: 10.25259/IJDVL_1246_2025
Dear Editor,
A 56-year-old man from Bihar, India, presented with gradually enlarging painless swellings in his right inguinal area for 4 months. He also reported weight loss of 10 kg in the last 3 months. He had a history of lepromatous leprosy treated with a 1-year course of the World Health Organization (WHO) multibacillary multi-drug treatment 20 years ago. On examination, there were multiple dusky red, firm-to-hard nodules measuring 3 cm × 4 cm on the right inguinal region, fixed to the underlying skin with surrounding induration [Figure 1a]. Further examination revealed a single large ulcer measuring 8 cm × 6 cm on the plantar aspect of the right forefoot. The ulcer margins were non-tender and hyperkeratotic with red, moist granulation tissue on the floor and an indurated base [Figure 1b]. On enquiring, the patient had noticed this plantar ulcer 1 year back.


Additional findings included distal resorption of the right great toe, flexion deformity of the right second and third toes, right ulnar claw hand, madarosis, bilateral ear lobe infiltration, and glove-and-stocking pattern of anaesthesia. A punch biopsy from the ulcer edge showed compact hyperparakeratosis, prominent irregular epidermal acanthosis, along with multiple scattered dyskeratotic keratinocytes, keratin pearl formation and focal suprabasal clefts with acantholytic cells [Figures 2a and b]. Biopsy of the inguinal nodule showed a deep dermal nodular collection of atypical cells with abundant pink cytoplasm and large hyperchromatic nuclei [Figures 2c and d]. The tumour cells were immunopositive for p40. A fine needle aspiration cytology examination of one of the enlarged inguinal lymph nodes showed sheets of dysplastic squamous epithelial cells, inflammatory cells and haemorrhage. A diagnosis of squamous cell carcinoma (SCC) complicating the trophic leprosy ulcer with lymph node metastases spreading to the overlying skin was made. A whole-body positron emission tomography-computed tomography (PET-CT) scan revealed a hypermetabolic ulcerative lesion in the right foot, causing erosion of phalanges of the 2nd, 3rd and 4th toes, enlarged right inguinal and external iliac nodes and multiple skeletal lesions, including the right foot, vertebrae, pelvis and skull [Figure 3]. He developed hypercalcaemia (serum calcium 17 mg/dL, reference range: 8.6-10.2 mg/dL) and acute renal failure (serum urea 170 mg/dL, reference range: 0.7-1.2 mg/dL) during his hospital stay, which was managed with intravenous hydration, injection calcitonin (250 IU subcutaneous, twice daily for 4 days) and haemodialysis. Given the unfavourable prognosis, he was discharged on palliative care.





SCC, complicating chronic wounds, including burn scars, venous ulcers, pressure sores and trophic ulcers, is well known and referred to as Marjolin ulcer.1 Malignant transformation in chronic non-healing leprosy ulcers is well-documented in older texts, with Indian studies reporting a prevalence of 3-14%.2-4 A Thai study reported 38 SCCs among 6,190 leprosy patients over a period of 10 years, translating to an incidence rate of 0.79 per 1,000 per year.5 Another study on skin biopsies of chronic leprosy ulcers found evidence of SCC in 24.5% of the specimens.6 SCCs arising on chronic leprosy ulcers usually affect the foot, particularly the sole.6 Most of the affected patients have been in the borderline-tuberculoid spectrum.3,5 The paucity of recent reports on this subject reflects better management of disabilities and trophic ulcers and the overall success of the leprosy elimination program. However, post-release from treatment (RFT) care is often overlooked.
Our patient presented with a metastatic SCC arising from a non-healing plantar ulcer, many years after being declared ‘cured.’ Neglect of the plantar ulcer resulted in SCC, and the delay in recognising malignant transformation led to advanced disease at diagnosis, lymph node and skeletal metastases, complicated by hypercalcaemia and renal dysfunction. This case represents an extreme consequence of the systemic gaps that persons affected by leprosy continue to suffer after treatment completion in the post-elimination era.
According to the WHO, about 3-4 million ‘cured’ leprosy patients are still living with visible impairments or deformities.7 Further, the disability grades continue to progress even after treatment release, as evidenced by a Brazilian study that reported a 35% probability of disability worsening over 15 years.8 A recent nationwide Indian study found that 26% of leprosy patients seeking medical care were in the post-RFT period, with trophic ulcers and deformities accounting for 13% and 12% of complaints, respectively.9
Through this case, we wish to highlight a critical lacuna in the care of persons affected by leprosy. National programs should integrate surveillance for post-treatment monitoring of disabilities and other complications to ensure effective rehabilitation of persons affected by leprosy. The WHO global leprosy document for 2021-30 also emphasises “functioning post-treatment surveillance systems” as one of the key indicators of progress. However, clear operational guidelines are lacking regarding which patients should be monitored, by whom, how frequently, and for how long. Our case underscores the unmet need for long-term follow-up of leprosy patients in the post-RFT period, not just for relapse detection but also to identify and manage disabilities and resulting complications.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form, the patients have given their consent for their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
Use of artificial intelligence (AI)-assisted technology for manuscript preparation
The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.
References
- Marjolin Ulcer. 2025 Apr 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025.
- [Google Scholar]
- Malignant transformation of plantar ulcers in leprosy. Indian J Lepr. 1993;65:297-303.
- [PubMed] [Google Scholar]
- Squamous cell carcinoma in plantar ulcers in leprosy: A study of 11 cases. Indian J Lepr. 2003;75:219-24.
- [PubMed] [Google Scholar]
- Comorbidities associated with non- healing of plantar ulcers in leprosy patients. PLoS Negl Trop Dis. 2020;14:e0008393.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Squamous cell carcinoma in chronic ulcers in leprosy: A review of 38 consecutive cases. Lepr Rev. 1991;62:381-8.
- [CrossRef] [PubMed] [Google Scholar]
- Squamous cell carcinoma arising in chronic ulcers in leprosy. J Med Assoc Thai. 2005;88:58-61.
- [PubMed] [Google Scholar]
- Global Leprosy (Hansen’s disease) Strategy 2021–2030. New Delhi: World Health Organization, Regional Office for South-East Asia; 2017.
- Disability progression among leprosy patients released from treatment: A survival analysis. Infect Dis Poverty. 2020;9:53.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
- Dermlep study part 3: Post-RFT events in leprosy patients presenting to dermatologists. Indian Dermatol Online J. 2022;13:340-5.
- [CrossRef] [PubMed] [PubMed Central] [Google Scholar]
